SUBSCRIBE
SUBSCRIBE

Beijing YiCheng Bioelectronics Lands $10.3 Million in Series A Funding

April 14, 2010 | 
1 min read
China Biotoday -- Beijing YiCheng Bioelectronics Technology Co. Ltd., China’s leading manufacturer of OTC blood glucose monitoring devices, closed a $10.3 million Series A funding, raising money from Sequoia Capital and PreIPO Capital.
Asia
MORE ON THIS TOPIC
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
August 7, 2025
 · 
1 min read
 · 
Lori Ellis
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
August 6, 2025
 · 
2 min read
 · 
Heather McKenzie
Businessmans hand holding a red globe with the map of China, symbolizing international business, trade, global markets, global influence, economics, or Chinese business ventures
China
Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive
August 6, 2025
 · 
7 min read
 · 
Leslie Zhen Liang
Collage of a man hand giving a one hundred dollar bill to a woman hand on a yellow circle on a beige scratched background
Deals
GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui
July 28, 2025
 · 
2 min read
 · 
Tristan Manalac